Myinfla Will Be a New Med for Coronary Artery Disease

You'll hear about Myinfla (extended-release colchicine) for patients with coronary artery disease (CAD).

We're used to seeing immediate-release colchicine 0.6 mg for patients with gout.

But there's growing interest in using colchicine for heart reduce the risk of cardiovascular (CV) events, such as heart attack, stroke, and angina.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote